Drugs / HPV 9-valent vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06882447 | Mar 2025 → Dec 2027 expected | cervical carcinoma | Northern Jiangsu People's Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HPV 9-valent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06882447 ↗ |
| Modality | Vaccine | “HPV 9-valent vaccine” NCT06882447 ↗ |